Missouri HB2961 establishes provisions for ibogaine treatment research and clinical trials.
HB2961 creates provisions for ibogaine treatment research and clinical trials in Missouri. The bill mandates the Department of Health and Senior Services to award grants for certified clinical drug development trials on ibogaine for opioid use treatment. It establishes the Ibogaine Study Fund and the Ibogaine Intellectual Property Fund. The bill also requires the department to submit an annual report on the progress and financial status of the trials. The fund will be used for programs assisting veterans and others affected by neurological conditions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.